1
|
Todorov P, Assenov B, Angelov D, Dzhambazova E, Pechlivanova D. Behavioral Effects and Analgesic Profile of Hemoglobin-Derived Valorphin and Its Synthetic Analog in Rodents. Biomedicines 2023; 11:2783. [PMID: 37893157 PMCID: PMC10603931 DOI: 10.3390/biomedicines11102783] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2023] [Revised: 10/09/2023] [Accepted: 10/12/2023] [Indexed: 10/29/2023] Open
Abstract
Valorphin (V1) is a naturally occurring peptide derived from hemoglobin that has been found to have an affinity for opioid receptors and exhibits antinociceptive and anticonvulsant activity. Some of its synthetic analogs containing an aminophosphonate moiety show structure-dependent potent antinociceptive effects. This study aimed to reveal a detailed picture of the antinociceptive mechanisms and behavioral effects of V1 and its recently synthesized phosphopeptide analog V2p in rodents using a range of methods. The studied peptides significantly reduced acute (mean V1-9.0, V2p-5.8 vs. controls-54.1 s) and inflammatory (mean V1-57.9 and V2p-53.3 vs. controls-107.6 s) nociceptive pain in the formalin test, as well as carrageenan-induced hyperalgesia (mean V1-184.7 and V2p-107.3 vs. controls-61.8 g) in the paw pressure test. These effects are mediated by activation of opioid receptors with a predominance of kappa in V1 antinociception and by delta, kappa, and mu receptors in V2p-induced antinociception. Both peptides did not change the levels of TNF-alpha and IL-1-beta in blood serum. V1 induces depression-like behavior, and V2p shows a tendency toward anxiolysis and short-term impairment of motor coordination without affecting exploratory behavior. The results characterize valorphin and its derivative as promising analgesics that exert their effects both centrally and peripherally, without causing severe behavioral changes in experimental animals. These encouraging data are a foundation for future studies focusing on the effects of hemorphins after long-term treatment.
Collapse
Affiliation(s)
- Petar Todorov
- Department of Organic Chemistry, University of Chemical Technology and Metallurgy, 1756 Sofia, Bulgaria;
| | - Borislav Assenov
- Institute of Neurobiology, Bulgarian Academy of Sciences, Acad. G. Bonchev Str., Bl. 23, 1113 Sofia, Bulgaria; (B.A.); (D.A.)
- Faculty of Medicine, Sofia University “St. Kliment Ohridski”, 1 Kozyak Str., 1407 Sofia, Bulgaria;
| | - Dimo Angelov
- Institute of Neurobiology, Bulgarian Academy of Sciences, Acad. G. Bonchev Str., Bl. 23, 1113 Sofia, Bulgaria; (B.A.); (D.A.)
| | - Elena Dzhambazova
- Faculty of Medicine, Sofia University “St. Kliment Ohridski”, 1 Kozyak Str., 1407 Sofia, Bulgaria;
| | - Daniela Pechlivanova
- Institute of Neurobiology, Bulgarian Academy of Sciences, Acad. G. Bonchev Str., Bl. 23, 1113 Sofia, Bulgaria; (B.A.); (D.A.)
- Faculty of Medicine, Sofia University “St. Kliment Ohridski”, 1 Kozyak Str., 1407 Sofia, Bulgaria;
| |
Collapse
|
2
|
Todorov P, Georgieva S, Tchekalarova J, Peneva P, Mateeva P, Assenov B, Dzhambazova E, Pechlivanova D. Synthesis, characterization and evaluation of anti-hyperalgesia, anticonvulsant and antioxidant activity of novel VV-hemorphin-5 analogs. Arch Pharm (Weinheim) 2023; 356:e2300267. [PMID: 37532631 DOI: 10.1002/ardp.202300267] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2023] [Revised: 07/04/2023] [Accepted: 07/17/2023] [Indexed: 08/04/2023]
Abstract
Two series of new VV-hemorphin-5 analogs with structures Val-Val-Tyr-Xxx-Trp-Thr-Gln-NH2 and Adam-Val-Val-Tyr-Xxx-Trp-Thr-Gln-NH2 , where Xxx is Ac5c (1-aminocyclopentane-1-carboxylic acid), Ac6c (1-aminocyclohexane-1-carboxylic acid), Ac7c (1-aminocycloheptane-1-carboxylic acid), and Adam is the low-molecular-weight lipophilic adamantyl building block, were synthesized, characterized electrochemically and evaluated for antioxidant, anti-hyperalgesia, and anticonvulsant activity. The design of the compounds followed the strategy to improve the propensity for aqueous solubility and/or to increase their affinity for the target receptor or enzyme. The partition coefficient value shows that the peptide scaffold goes from hydrophilic to lipophilic with the increasing size of the cycloalkane ring and even more with the introduction of the adamantane. The peptides C5-V and C7-V were the only analogs that provoked an immediate antinociceptive effect changing the mechanical pain threshold. The six new peptide analogs produced a significant and long-lasting carrageenan model of inflammatory pain in rats. While the adamantane hemorphin analog Ad7-V was the only compound with the potency to suppress psychomotor seizures in the 6-Hz test, the C6-V and Ad6-V exhibited protective activity against the seizure spread in the maximal electroshock seizure test in mice. The active analogs did not show neurotoxicity or sedative effects. Our results revealed a structure-related specific activity of a newly designed hemorphin analog that could be used as a template for future modification and preparation of compounds with potential analgesic and anticonvulsant activity.
Collapse
Affiliation(s)
- Petar Todorov
- Department of Organic Chemistry, University of Chemical Technology and Metallurgy, Sofia, Bulgaria
| | - Stela Georgieva
- Department of Analytical Chemistry, University of Chemical Technology and Metallurgy, Sofia, Bulgaria
| | - Jana Tchekalarova
- Department of Organic Chemistry, University of Chemical Technology and Metallurgy, Sofia, Bulgaria
- Institute of Neurobiology, Bulgarian Academy of Sciences, Sofia, Bulgaria
| | - Petia Peneva
- Department of Organic Chemistry, University of Chemical Technology and Metallurgy, Sofia, Bulgaria
| | - Polina Mateeva
- Institute of Neurobiology, Bulgarian Academy of Sciences, Sofia, Bulgaria
| | - Borislav Assenov
- Institute of Neurobiology, Bulgarian Academy of Sciences, Sofia, Bulgaria
- Faculty of Medicine, Sofia University "St. Kliment Ohridski", Sofia, Bulgaria
| | - Elena Dzhambazova
- Faculty of Medicine, Sofia University "St. Kliment Ohridski", Sofia, Bulgaria
| | - Daniela Pechlivanova
- Institute of Neurobiology, Bulgarian Academy of Sciences, Sofia, Bulgaria
- Faculty of Medicine, Sofia University "St. Kliment Ohridski", Sofia, Bulgaria
| |
Collapse
|
3
|
Assenov B, Pechlivanova D, Dzhambazova E, Peneva P, Todorov P. Antinociceptive Effects of VV-Hemorphin-5 Peptide Analogues Containing Amino phosphonate Moiety in Mouse Formalin Model of Pain. Protein Pept Lett 2021; 28:442-449. [PMID: 32798365 DOI: 10.2174/0929866527666200813200714] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2020] [Revised: 06/19/2020] [Accepted: 06/21/2020] [Indexed: 11/22/2022]
Abstract
BACKGROUND Hemorphins are endogenous hemoglobin-derived peptides that belong to the family of "atypical" opioid peptides with both affinities to opioid receptors and ability to release other endogenous opioid peptides. OBJECTIVE In the present study, peptide analogues of Valorphin (VV-hemorphin-5) containing amino phosphonate moiety synthesized by solid-phase peptide synthesis (Fmoc-strategy) were investigated for their potential antinociceptive activities and compared to the reference VV-H in formalin- induced model of acute and inflammatory pain in mice. METHODS The hemorphin analogues were prepared by replacement of the one and/or two N-terminal Val in VV-hemorphin5 (VV-H) with ((dimethoxy phosphoryl) methyl)-L-valine and ((dimethoxy phosphoryl) methyl)-L-leucine to obtain the compounds pVV-H, pL-H, and pLV-H. Aiming to additionally prove the importance of amino acid valine, we introduced the ((dimethoxy phosphoryl) methyl)-L-leucine to the N-side of VV-hemorphin-5 (pLVV-H). The experiments were carried out on adult male ICR mice. All peptides were administered intracerebroventricularly at three doses (50, 25 and 12,5 μg/mouse). We have studied the effects of the peptides on acute (1st phase) and inflammatory (2nd phase) pain reaction using un experimental model with intraplantar formalin injection. RESULTS VV-H showed a significant antinociceptive effect both in the acute and inflammatory phases of the test. Although Valorphin hexa-, hepta-, and octapeptide analogs demonstrated a significant antinociceptive effect, they showed substantial differences considering their effective dose and the phase of the test as compared to the Valorphin. DISCUSSION Data showed that modified heptapeptides pVV-H and pLV-H exerted the same or better antinociception in acute and inflammatory pain, in comparison to the reference peptide, while pL-H and pLVV-H analogues were less effective. CONCLUSION Our study contributes to the elucidation of the role of Valine and the number of amino acid residues in the structure of hemorphin peptide analogs in their effectiveness in suppressing both acute and inflammatory experimental pain.
Collapse
Affiliation(s)
- Borislav Assenov
- Sofia University "St. Kliment Ohridski", Medical Faculty, Sofia 1407, Bulgaria
| | | | - Elena Dzhambazova
- Sofia University "St. Kliment Ohridski", Medical Faculty, Sofia 1407, Bulgaria
| | - Petia Peneva
- Department of Organic Chemistry, University of Chemical Technology and Metallurgy, Sofia 1756, Bulgaria
| | - Petar Todorov
- Department of Organic Chemistry, University of Chemical Technology and Metallurgy, Sofia 1756, Bulgaria
| |
Collapse
|
4
|
Angelova H, Krumova E, Dzhambazova E, Pechlivanova D. Effects of the antinociceptive dipeptide L-tyrosine-L-arginine (kyotorphin) on the motivation, anxiety, and memory in rats. Folia Med (Plovdiv) 2021; 63:189-196. [PMID: 33932008 DOI: 10.3897/folmed.63.e53912] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2020] [Accepted: 06/15/2020] [Indexed: 11/12/2022] Open
Abstract
INTRODUCTION The endogenous dipeptide L-tyrosine-L-arginine (kyotorphin, KTP) is found in brain structures related to the processing of information for nociception, the control of emotions, and memory formation. Besides the antinociceptive effect of KTP, it has a mild protective activity against the deleterious influence of the brain hypoperfusion and streptozotocin on the behavior and memory. AIM We aimed to study the effects of the intracerebroventricular injection of effective antinociceptive doses of KTP on the motivational behavior, memory, and blood and hippocampal levels of the carbonylated proteins in healthy male adult Wistar rats. MATERIALS AND METHODS We used a paw-pressure test for assessment of acute nociception, an open field test for assessment of exploration and habituation to a new environment, elevated plus maze test for the evaluation of anxiety-like behavior, and novel object recognition test for working memory. Carbonylated protein assay was used for the assessment of the oxidative impairment of the proteins. The results were analyzed by ANOVA. RESULTS The present data showed that all single doses of KTP exerted an antinociceptive effect, but this effect was not observed after chronic administration. Only the highest dose of 100 µg was able to induce anxiolytic and motor inhibiting effects. None of the doses used showed effects on the recognition memory or the level of the carbonylated protein. CONCLUSION Our results showed that KTP exerted its antinociceptive effect without affecting negatively the blood and brain carbonylated protein or basic behavioral parameters related to the exploration, motivation, and memory formation in healthy rats.
Collapse
Affiliation(s)
- Hristina Angelova
- Insitute of Neurobiology, Bulgarian Academy of Sciences, Sofia, Bulgaria
| | - Ekaterina Krumova
- Institute of Microbiology, Bulgarian Academy of Sciences,, Sofia, Bulgaria
| | | | | |
Collapse
|
5
|
Stanchev S, Stamenov N, Kirkov V, Dzhambazova E, Nikolov D, Paloff A. Differential collagen expression in kidney and heart during hypertension. ACTA ACUST UNITED AC 2020; 121:73-78. [PMID: 31950843 DOI: 10.4149/bll_2020_011] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
AIM The aim of the present study was to investigate the immunohistochemical expression of selected collagen types, namely collagen types I and V and procollagen type III in the renal parenchyma and interstitium and in the myocardium of spontaneously hypertensive rats. MATERIAL AND METHODS For the present study, we used two age groups of 6- and 12-month-old spontaneously hypertensive rats. An immunohistochemical analysis was conducted with monoclonal antibodies against collagen types I and V and procollagen type III. A semi-quantitative analysis of immunostaining intensity was conducted with the Image J software. RESULTS In the kidney, all three molecules showed higher expression at the age of 12 months, which was particularly notable for procollagen type III and collagen type V, which stained as highly-positive. In the myocardium, the immunoreactivity of collagen types I and V was stronger in 12-month-old animals, while that of procollagen type III did not change substantially. CONCLUSION The present study suggests a role of collagen types III and V in hypertensive kidney disease, while also establishing the role of increased expression of collagen types I and V in adverse myocardial remodeling (Tab. 1, Fig. 2, Ref. 48).
Collapse
|
6
|
Todorov P, Peneva P, Pechlivanova D, Georgieva S, Dzhambazova E. Synthesis, characterization and nociceptive screening of new VV-hemorphin-5 analogues. Bioorg Med Chem Lett 2018; 28:3073-3079. [PMID: 30078474 DOI: 10.1016/j.bmcl.2018.07.040] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2018] [Revised: 07/25/2018] [Accepted: 07/29/2018] [Indexed: 12/19/2022]
Abstract
In the present study, some new analogues of VV-hemorphin-5, modified at position 1 and 7 by the non-proteinogenic and/or natural amino acids followed the structures Xxx-Val-Val-Tyr-Pro-Trp-Thr-Gln-NH2 and Val-Val-Tyr-Pro-Trp-Thr-Yyy-NH2, where Xxx is Ile or Aib and Yyy is Lys/Orn/Dap/Dab were synthesized to investigate their potential antinociceptive activities. We report also the redox potentials and the acid/base properties as pKa values of these peptide analogues which were compared toward electrochemical behaviour of tryptophan containing peptides. All analogues showed a short lasting initial antinociceptive effect, however H2 hemorphin analogue is characterized with prolong and strong antinociceptive effect, while the other peptide analogues exerted more variable effects on the visceral nociception depending on the dose or time after the intracerebral injection.
Collapse
Affiliation(s)
- Petar Todorov
- Department of Organic Chemistry, University of Chemical Technology and Metallurgy, 1756 Sofia, Bulgaria.
| | - Petia Peneva
- Department of Organic Chemistry, University of Chemical Technology and Metallurgy, 1756 Sofia, Bulgaria
| | | | - Stela Georgieva
- Department of Analytical Chemistry, University of Chemical Technology and Metallurgy, 1756 Sofia, Bulgaria
| | - Elena Dzhambazova
- Department of Chemistry, Biochemistry, Physiology and Pathophysiology, Faculty of Medicine, Sofia University "St. Kliment Ohridski", 1407 Sofia, Bulgaria
| |
Collapse
|
7
|
Landzhov B, Hinova-Palova D, Edelstein L, Dzhambazova E, Brainova I, Georgiev GP, Ivanova V, Paloff A, Ovtscharoff W. Comparative investigation of neuronal nitric oxide synthase immunoreactivity in rat and human claustrum. J Chem Neuroanat 2017; 86:1-14. [DOI: 10.1016/j.jchemneu.2017.07.003] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2017] [Revised: 07/05/2017] [Accepted: 07/06/2017] [Indexed: 01/22/2023]
|
8
|
Hinova-Palova D, Landzhov B, Dzhambazova E, Edelstein L, Minkov M, Fakih K, Minkov R, Paloff A, Ovtscharoff W. NADPH-diaphorase-positive neurons in the human inferior colliculus: morphology, distribution and clinical implications. Brain Struct Funct 2016; 222:1829-1846. [DOI: 10.1007/s00429-016-1310-1] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2015] [Accepted: 09/11/2016] [Indexed: 12/18/2022]
|
9
|
Hinova-Palova DV, Landzhov B, Dzhambazova E, Minkov M, Edelstein L, Malinova L, Paloff A, Ovtscharoff W. Neuropeptide Y immunoreactivity in the cat claustrum: A light- and electron-microscopic investigation. J Chem Neuroanat 2014; 61-62:107-19. [PMID: 25157673 DOI: 10.1016/j.jchemneu.2014.08.007] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2014] [Revised: 08/15/2014] [Accepted: 08/16/2014] [Indexed: 11/28/2022]
Abstract
The claustrum is a telencephalic nucleus located ventrolateral to the basal ganglia in the mammalian brain. It has an extensive reciprocal connectivity with most if not all of the cerebral cortex, in particular, primary sensory areas. However, despite renewed and growing interest amongst investigators, there remains a paucity of data concerning its peptidergic profile. The aim of the present study was to examine the presence, morphology, distribution and ultrastructure of neuropeptide Y-immunoreactive (NPY-ir) neurons and fibers in the claustrum of the cat. Ten adult healthy cats from both sexes were used. All animals received human and ethical treatment in accordance with the Principles of Laboratory Animal Care. Subjects were irreversibly anesthetized and transcardially perfused with fixative solution containing glutaraldehyde and paraformaldehyde. Brains were promptly removed, postfixed and sectioned. Slices were incubated with polyclonal anti-NPY antibodies according to the standard avidin-biotin-peroxidase complex method adopted by our Department of Anatomy, Histology and Embryology. NPY-ir neurons and fibers were found to be diffusely distributed throughout the claustrum, with no obvious topographic or functional patterning other than larger numbers in its central/broadest part (stereotaxic planes A12-A16). Neurons were generally classified by diameter into three sizes: small (under 17 μm), medium (17-25 μm) and large (over 25 μm). Staining density is varied with some neurons appearing darker than others. At the electron-microscopic level NPY immunoproduct was observed within neurons, dendrites and terminal boutons, each differing relative to their ultrastructural attributes. Two types of NPY-ir synaptic boutons were found. Lastly, it is of interest to note that gender-specific differences were not observed.
Collapse
Affiliation(s)
- D V Hinova-Palova
- Department of Anatomy, Histology and Embryology, Medical University of Sofia, 1431 Sofia, Bulgaria
| | - B Landzhov
- Department of Anatomy, Histology and Embryology, Medical University of Sofia, 1431 Sofia, Bulgaria.
| | - E Dzhambazova
- Department of Chemistry, Biochemistry, Physiology and Pathophysiology, Sofia University "St. Kliment Ohridski", 1407 Sofia, Bulgaria
| | - M Minkov
- Department of Anatomy, Histology and Embryology, Medical University of Varna, 9002 Varna, Bulgaria
| | - L Edelstein
- Medimark Corporation, P.O. Box 2316, Del Mar, CA 92014, USA
| | - L Malinova
- Department of Anatomy, Histology and Embryology, Medical University of Sofia, 1431 Sofia, Bulgaria
| | - A Paloff
- Department of Anatomy, Histology and Embryology, Medical University of Sofia, 1431 Sofia, Bulgaria
| | - W Ovtscharoff
- Department of Anatomy, Histology and Embryology, Medical University of Sofia, 1431 Sofia, Bulgaria
| |
Collapse
|
10
|
Jlalia I, Lensen N, Chaume G, Dzhambazova E, Astasidi L, Hadjiolova R, Bocheva A, Brigaud T. Synthesis of an MIF-1 analogue containing enantiopure (S)-α-trifluoromethyl-proline and biological evaluation on nociception. Eur J Med Chem 2013; 62:122-9. [PMID: 23353749 DOI: 10.1016/j.ejmech.2012.12.041] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2012] [Revised: 12/19/2012] [Accepted: 12/23/2012] [Indexed: 11/16/2022]
Abstract
The synthesis and the effect of a novel MIF-1 analogue on nociception during acute pain in rat model are reported. The synthesis of this enantiopure trifluoromethyl group containing tripeptide was performed through a peptide coupling reaction between the HCl. Leu-Gly-NH2 and the (S)-α-Tfm-proline. The analgesic effect of the CF3-(MIF-1) 2 has been evaluated in vivo on rat model by paw pressure (PP) and hot plate (HP) tests and compared to the native peptide MIF-1. Highest analgesic effect was observed with CF3-(MIF-1) 2 only in PP test. In order to study the mechanisms of nociception induced by the studied peptides, the involvement of the opioid and the nitric oxideergic systems was investigated. The results are in favor of a participation of both system since pretreatment, 20 min before injection of the CF3-(MIF-1) 2, with the non-competitive antagonist of opiate receptors naloxone, the nitric oxide synthase (NOS) inhibitor l-N(G)-nitroarginine ester (l-NAME) or the nitric oxide (NO) donor l-arginine (l-Arg) significantly decreased the pain perception in PP and HP tests.
Collapse
Affiliation(s)
- Ibtissem Jlalia
- Laboratoire SOSCO, Université de Cergy-Pontoise, EA 4505, 5 Mail Gay Lussac, Neuville sur Oise, 95000 Cergy-Pontoise Cedex, France
| | | | | | | | | | | | | | | |
Collapse
|
11
|
Enchev E, Botushanov N, Dzhambazova E. [Bone mineral density in healthy premenopausal Bulgarian women of 40-49 years of age]. Akush Ginekol (Sofiia) 2007; 46:41-4. [PMID: 17469462] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/15/2023]
Abstract
UNLABELLED Osteoporosis is a disease that have a great impact upon health and well being amongst the elderly population worldwide. Bone mineral density /BMD/ is currently the most powerful and worldwide accepted determinant for the future risk of fractures. AIM To investigate and evaluate the values of the BMD of the spine /L2-L4/in anterior-posterior position by dual X-ray absorbtiometry in healthy and with preserved menstruation Bulgarian women between 40-44 and 45-49 years of age. MATERIALS AND METHODS 186 women between 40 -44 years and 106 women between 45-49 years of age with preserved menstruation were included in the study. Age, height and body weight were recorded to each of them. BMD in g/cm(2) was measured on LUNAR-DPX -A version 1.15 bone densitometer at L2-L4 in anterior-posterior position. RESULTS The younger group of women between 40 and 44 years of age showed with 0, 049 g/cm(2) /4,2% / higher BMD of the measured vertebrae in comparison with the BMD of the women between 45-45 years. In both groups body weight correlates positively with BMD. The analyses of the mean values of BMD /L2-L4/ in healthy and with preserved menstruation Bulgarian women shows an interval between 1.011 g/cm(2) and 1.321 g/cm(2) for the women 40-44 years old and between 0.947 g/cm(2) and 1.287 g/cm(2) for the group of women between 45-49 years /CI -0.95/. The comparison of the BMD between both groups shows reduction of 4.2% which makes a physiological bone loss of 0. 7% annually. CONCLUSIONS The higher body weight in the Bulgarian women is protective, but it is not the only determinant of the lumbar bone mineral density and bone loss.
Collapse
|
12
|
Enchev E, Botushanov N, Dzhambazova E. [Bone mineral density in premenopausal and postmenopausal women between 50-55 and 50-57 years of age]. Akush Ginekol (Sofiia) 2007; 46:14-7. [PMID: 17469445] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/15/2023]
Abstract
AIM To investigate and evaluate the values of the BMD of the spine /L2-L4/ in anterior-posterior position by dual X-ray absorbtiometry in premenopausal women between 50-55 years and postmenopausal women between 50-57 years of age. MATERIALS AND METHODS 93 healthy and with preserved menstruation women between 50-57 years and 112 postmenopausal women between 50-57 years of age were included in the study. BMD in g/cm2 was measured by dual X-ray absorbtiometry on LUNAR-DPX-A version 1.15 bone densitometer at L2-L4 in anterior-posterior position. RESULTS The BMD L2-L4 of the premenopausal women is statistically significant higher than that of the postmenopausal group. The correlation analyses between BMD and the other investigated variables shows a positive correlation between BMD and the body weight in the postmenopausal group and a weak negative correlation between BMD and the years of menopause. CONCLUSIONS The lower values of the coefficient of determination R2 in both groups can not allow us to predict the individual values of BMD based only upon the body weight. The years of menopause also have no predictable value for the BMD in the postmenopausal group.
Collapse
|